Asymmetric post-translational modifications regulate the nuclear translocation of STAT3 homodimers in response to leukemia inhibitory factor
Cellular Oncology · 2024
DOI: 10.1007/s13402-023-00911-9 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cellular Oncology, 2024. Verfasst von Mickael Diallo und 10 weiteren Autor:innen. Beteiligte Einrichtung: BioISI - Instituto de Biosistemas e Ciências Integrativas, Faculdade de Ciências da Universidade de Lisboa, Lisbon, 1749-016, Portugal. Hauptthemen laut MEDLINE: Cell Nucleus, Leukemia Inhibitory Factor, Protein Multimerization, Protein Processing, Post-Translational. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 24 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Universidade de Lisboa.
Abstract (Originalsprache)
STAT3 is a pleiotropic transcription factor overactivated in 70% of solid tumours. We have recently reported that inactivating mutations on residues susceptible to post-translational modifications (PTMs) in only one of the monomers (i.e. asymmetric) caused changes in the cellular distribution of STAT3 homodimers. Here, we used more controlled experimental conditions, i.e. without the interference of endogenous STAT3 (STAT3-/- HeLa cells) and in the presence of a defined cytokine stimulus (Leukemia Inhibitory Factor, LIF), to provide further evidence that asymmetric PTMs affect the nuclear translocation of STAT3 homodimers. Time-lapse microscopy for 20 min after LIF stimulation showed that S727 dephosphorylation (S727A) and K685 inactivation (K685R) slightly enhanced the nuclear translocation of STAT3 homodimers, while K49 inactivation (K49R) delayed STAT3 nuclear translocation. Our findings suggest that asymmetrically modified STAT3 homodimers could be a new level of STAT3 regulation and, therefore, a potential target for cancer therapy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- BioISI - Instituto de Biosistemas e Ciências Integrativas, Faculdade de Ciências da Universidade de Lisboa, Lisbon, 1749-016, Portugal.
- MOSTMICRO Research Unit, Instituto de Tecnologia Química e Biológica (ITQB-NOVA), Universidade Nova de Lisboa, Oeiras, Portugal.
- Departamento de Morfología y Biología Celular, Facultad de Medicina, University of Oviedo, c/Julian Claveria, Oviedo, 33006, Spain.
- Instituto Universitario de Oncología del Principado de Asturias (IUOPA), Oviedo, Spain.
- BioISI - Instituto de Biosistemas e Ciências Integrativas, Faculdade de Ciências da Universidade de Lisboa, Lisbon, 1749-016, Portugal. fherrera@fc.ul.pt.
Förderung
- Universidade de Lisboa
Zitieren
APA
Diallo, M., Pimenta, C., Murtinheira, F., Martins-Alves, D., Pinto, F. R., da Costa, A. A., Letra-Vilela, R., Martin, V., Rodriguez, C., Rodrigues, M. S., & Herrera, F. (2024). Asymmetric post-translational modifications regulate the nuclear translocation of STAT3 homodimers in response to leukemia inhibitory factor. Cellular Oncology. https://doi.org/10.1007/s13402-023-00911-9
Vancouver
Diallo M, Pimenta C, Murtinheira F, Martins-Alves D, Pinto FR, da Costa AA, et al. Asymmetric post-translational modifications regulate the nuclear translocation of STAT3 homodimers in response to leukemia inhibitory factor. Cellular Oncology. 2024. doi:10.1007/s13402-023-00911-9
BibTeX
@article{Diallo2024,
author = {Diallo, Mickael and Pimenta, Constança and Murtinheira, Fernanda and Martins-Alves, Daniela and Pinto, Francisco R and da Costa, André Abrantes and Letra-Vilela, Ricardo and Martin, Vanesa and Rodriguez, Carmen and Rodrigues, Mário S and Herrera, Federico},
title = {Asymmetric post-translational modifications regulate the nuclear translocation of STAT3 homodimers in response to leukemia inhibitory factor},
journal = {Cellular Oncology},
year = {2024},
doi = {10.1007/s13402-023-00911-9}
}
EUVIMED